EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

H. Yamaguchi, Y. Du, K. Nakai, M. Ding, S. S. Chang, J. L. Hsu, J. Yao, Y. Wei, L. Nie, S. Jiao, W. C. Chang, C. H. Chen, Y. Yu, G. N. Hortobagyi, M. C. Hung

Research output: Contribution to journalArticle

19 Scopus citations

Fingerprint Dive into the research topics of 'EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences